Skip to main content

  • Comparison of Coronary Artery Bypass Grafting and Drug-Eluting Stents in Patients with Left Main Coronary Artery Disease and Chronic Kidney Disease: A Systematic Review and Meta-Analysis

    • Posted: 12/23/2019
    • Author:

       

      Mahmoud Barbarawi, Yazan Zayed, Kewan Hamid, Babikir Kheiri, ... Mohammad Luay Alkotob

       

    • 2019CRM

    Highlights

    • Chronic kidney disease is a risk factor of cardiovascular disease.
    • Left main disease treatment is still controversial in patients with Chronic kidney disease.

    Abstract

    Background

    Treatment of left main coronary artery disease (LMCAD) in patients with chronic kidney disease (CKD) with either percutaneous coronary intervention (PCI) or coronary artery bypass grafting (CABG) remains controversial. Therefore, we performed a meta-analysis to evaluate the optimal choice of therapy when treating LMCAD in patients with CKD.

This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies. Review our Privacy Policy for more details